Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen T Holgate

Showing results (51-60 of 232) with videos related to

Pageof 24
Sort By:
Lancet (London, England)|October 29, 2002
Air pollution and healthBert Brunekreef, Stephen T Holgate
Current Drug Targets|June 22, 2006
Adenosine receptors as promising therapeutic targets for drug development in chronic airway inflammationRiccardo Polosa, Stephen T Holgate
Nature Reviews. Drug Discovery|December 12, 2003
New targets for allergic rhinitis--a disease of civilizationStephen T Holgate, David Broide
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Targeting adenosine receptors: novel therapeutic targets in asthma and chronic obstructive pulmonary diseaseSteuart Rorke, Stephen T Holgate
Advances in Experimental Medicine and Biology|May 31, 2011
The role of histamine in asthmaPaul J Dunford, Stephen T Holgate
The Journal of Allergy and Clinical Immunology|January 18, 2003
Introduction: the anti-inflammatory role of cysteinyl leukotriene receptor antagonists in asthmaStephen T Holgate, Marc Peters-Golden
Current Allergy and Asthma Reports|March 16, 2002
Mast cell tryptase as a proinflamatory mediator in late-phase asthmatic responseStephen T Holgate, Sundeep S Salvi
The Indian Journal of Chest Diseases & Allied Sciences|May 25, 2002
Newer therapies for asthma: a focus on anti-IgEK Suresh Babu, Stephen T Holgate
Clinical Allergy and Immunology|July 13, 2002
H1-antihistamines in asthmaJames L Lordan, Stephen T Holgate
Expert Opinion on Investigational Drugs|March 5, 2004
New strategies in the treatment and prevention of allergic diseasesHans Michael Haitchi, Stephen T Holgate
Pageof 24

Showing results (51-60 of 232) with videos related to

Sort By:
Pageof 24
Lancet (London, England)|October 29, 2002
Air pollution and healthBert Brunekreef, Stephen T Holgate
Current Drug Targets|June 22, 2006
Adenosine receptors as promising therapeutic targets for drug development in chronic airway inflammationRiccardo Polosa, Stephen T Holgate
Nature Reviews. Drug Discovery|December 12, 2003
New targets for allergic rhinitis--a disease of civilizationStephen T Holgate, David Broide
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Targeting adenosine receptors: novel therapeutic targets in asthma and chronic obstructive pulmonary diseaseSteuart Rorke, Stephen T Holgate
Advances in Experimental Medicine and Biology|May 31, 2011
The role of histamine in asthmaPaul J Dunford, Stephen T Holgate
The Journal of Allergy and Clinical Immunology|January 18, 2003
Introduction: the anti-inflammatory role of cysteinyl leukotriene receptor antagonists in asthmaStephen T Holgate, Marc Peters-Golden
Current Allergy and Asthma Reports|March 16, 2002
Mast cell tryptase as a proinflamatory mediator in late-phase asthmatic responseStephen T Holgate, Sundeep S Salvi
The Indian Journal of Chest Diseases & Allied Sciences|May 25, 2002
Newer therapies for asthma: a focus on anti-IgEK Suresh Babu, Stephen T Holgate
Clinical Allergy and Immunology|July 13, 2002
H1-antihistamines in asthmaJames L Lordan, Stephen T Holgate
Expert Opinion on Investigational Drugs|March 5, 2004
New strategies in the treatment and prevention of allergic diseasesHans Michael Haitchi, Stephen T Holgate
Pageof 24